市場調查報告書
商品編碼
1465144
基因表現分析市場:按產品、應用和最終用戶分類 - 2024-2030 年全球預測Gene Expression Analysis Market by Offering (Instruments, Reagents & Consumables, Services), Application (Clinical Diagnostics, Drug Discovery & Development), End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年基因表現分析市場規模為40億美元,2024年達43億美元,2030年預計將達67.7億美元,複合年成長率為7.80%。
基因表現分析是指研究基因轉錄和翻譯為蛋白質的模式和水平的過程,突顯基因在各種生物背景下的功能成分。該分析涉及量化不同條件、組織或時間點下基因的表達水平,以闡明它們在生理或病理條件下的調節機制、相互作用和作用。從基因表現分析中獲得的見解對於了解疾病的分子基礎、確定潛在的治療標靶和開發個人化醫療方法至關重要。在高通量和次世代定序等技術進步的推動下,基因表現分析市場正在快速發展,從而降低了成本並提高了效率。隨著遺傳疾病和癌症發生率的增加,在基因組學研究方面的大量公共和私人投資的推動下,診斷和研究領域對精確基因表現研究的需求不斷增加。然而,市場面臨重大障礙,包括嚴格的法律規範延長了產品開發時間並增加了成本,以及管理和解釋所產生的大量資料的複雜性。儘管存在這些挑戰,未來的市場機會在於人們對個人化醫療以及人工智慧和機器學習的整合以簡化資料分析的興趣日益濃厚。
主要市場統計 | |
---|---|
基準年[2023] | 40億美元 |
預測年份 [2024] | 43億美元 |
預測年份 [2030] | 67.7億美元 |
複合年成長率(%) | 7.80% |
更多採用具有特異性和擴充性的先進設備
用於基因表現分析的設備包括即時PCR(qPCR) 系統、次世代定序儀(NGS) 平台、微陣列和其他用於測量基因表現量的專用設備。微陣列掃描儀透過螢光掃描 DNA 微陣列玻片進行操作,在基因表現分析中發揮重要作用。這些儀器可實現高通量分析,使研究人員能夠同時分析多個樣本中大量基因的表現。 NGS 平台對於現代基因組研究至關重要,並提供更深入的資料。聚合酵素鏈鎖反應(PCR) 是一種廣泛使用的擴增特定 DNA 序列的技術,已成為基因表現分析的重要工具,尤其是定量 mRNA 水平的工具。即時PCR因其準確性、靈敏度和速度而成為檢測和定量核酸的新標準。
試劑和耗材包括執行基因表現分析所需的所有輸入,例如 PCR 試劑、緩衝液、引子、探針和專為特定平台和應用設計的套件。檢測方法和套件對於各種基因研究和臨床診斷應用的基因表現分析至關重要。這些產品旨在簡化、加速和改進基因表現研究。 DNA 微陣列技術為同時分析數千個基因的表現模式提供了強大的平台。這項技術使研究人員能夠全面了解疾病的機制、遺傳變異和細胞路徑。酵素是基因表現分析工作流程中的關鍵試劑,可實現逆轉錄、DNA 擴增和 cDNA 合成等各種重要過程。各種類型的酶,例如逆轉錄酶、DNA聚合酵素和連接酶,都可以找到特定於基因表現分析技術的應用。
基因表現分析服務包括諮詢、客自訂分析設計、樣品製備、定序、資料分析和解釋。這些通常由專業公司或卓越學術中心向沒有必要設備或專業知識的研究人員提供。
基因表現分析在提高藥物發現標靶識別應用效率的重要性日益增強
基因表現分析對於臨床診斷至關重要,能夠識別疾病特異性生物標記並促進個人化治療計劃。透過分析患者樣本中的基因表現水平,醫療保健相關人員可以在分子層面診斷疾病、預測疾病進展並監測患者對治療的反應。在藥物發現和藥物開發中,基因表現分析用於識別潛在的藥物標靶,了解新藥的作用機制,並預測藥物的功效和毒性。這將使開發更有效、更安全的藥物成為可能,顯著改善藥物開發平臺。
區域洞察
美洲尤其是北美的基因表現分析市場正呈現顯著成長。這是由於多種因素造成的,包括先進的醫療基礎設施、對生物技術和藥物研究的大量投資以及大型市場參與者的存在。美國國立衛生美國(NIH) 等政府機構的舉措以及學術機構和生物製藥公司之間的合作也為該地區的強勁成長做出了貢獻。慢性病和遺傳患者病率的上升以及與醫療保健研究相關的政府支持政策解釋了歐洲基因表現分析技術的高採用率。對研究基礎設施的投資和對改善醫療保健日益成長的興趣,特別是在波灣合作理事會(GCC) 國家,是推動 EMEA 市場的關鍵因素。亞太地區是一個快速成長的基因表現分析市場,藥物發現和市場開拓的研究活動不斷增加,醫療保健支出不斷增加,人們對遺傳疾病的認知也不斷提高。此外,旨在加強生物技術和製藥行業的政府舉措以及學術機構和行業之間的合作,極大地支持了該地區的市場成長。
FPNV定位矩陣
FPNV定位矩陣對於評估基因表現分析市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對基因表現分析市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.基因表現分析市場的市場規模與預測是多少?
2.在基因表現分析市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.基因表現分析市場的技術趨勢與法規結構是什麼?
4.基因表現分析市場主要廠商的市場佔有率為何?
5.進入基因表現分析市場合適的型態和策略手段是什麼?
[188 Pages Report] The Gene Expression Analysis Market size was estimated at USD 4.00 billion in 2023 and expected to reach USD 4.30 billion in 2024, at a CAGR 7.80% to reach USD 6.77 billion by 2030.
Gene expression analysis refers to the process of studying the patterns and levels at which genes are transcribed and translated into proteins, underscoring the functional elements of genes in various biological contexts. This analysis encompasses quantifying the expression levels of genes across different conditions, tissues, or time points to elucidate their regulatory mechanisms, interactions, and roles in physiological or pathological states. The insights gained from gene expression analysis are pivotal for understanding the molecular foundations of diseases, identifying potential therapeutic targets, and developing personalized medicine approaches. The gene expression analysis market is undergoing rapid evolution propelled by technological advancements, such as high-throughput and next-generation sequencing, which have improved efficiency while reducing costs. This, alongside the increasing incidence of genetic disorders and cancer, raises the need for precise gene expression studies in both diagnostic and research realms, further buoyed by substantial investments from public and private entities in genomics research. However, the market faces substantial hurdles, including stringent regulatory frameworks that lengthen product development timelines and elevate costs, as well as the complexities associated with managing and interpreting vast amounts of data generated. Despite these challenges, future market opportunities lie in the rising interest in personalized medicine and the integration of artificial intelligence and machine learning to streamline data analysis.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.00 billion |
Estimated Year [2024] | USD 4.30 billion |
Forecast Year [2030] | USD 6.77 billion |
CAGR (%) | 7.80% |
Offering: Growing adoption of advanced instruments with specificity and scalability
Instruments for gene expression analysis include real-time PCR (qPCR) systems, next-generation sequencing (NGS) platforms, microarrays, and other specialized equipment used in measuring the expression levels of genes. Microarray scanners are instrumental in gene expression analysis, operating by fluorescently scanning DNA microarray slides. These devices enable high-throughput analysis, allowing researchers to simultaneously analyze the expression of a number of genes within multiple samples. NGS platforms are crucial to modern genomics research, providing an enhanced depth of data. Polymerase chain reaction (PCR) is a widely used technique that amplifies specific DNA sequences, making it a crucial tool for gene expression analysis, particularly in quantifying mRNA levels. Real-time PCR has become the new standard for detecting and quantifying nucleic acids owing to its precision, sensitivity, and speed.
Reagents and consumables encompass all the necessary inputs required to perform gene expression analysis, such as PCR reagents, buffers, primers, probes, and kits designed for specific platforms or applications. Assays and kits are pivotal in gene expression analysis for various genetic research and clinical diagnostic applications. These products are designed to simplify, expedite, and enhance the accuracy of gene expression studies. DNA microarray technology offers a powerful platform for the simultaneous analysis of the expression patterns of thousands of genes. This technology enables researchers to gain comprehensive insights into the underlying mechanisms of diseases, genetic variations, and cellular pathways. Enzymes are pivotal reagents in the gene expression analysis workflow, enabling various critical processes such as reverse transcription, DNA amplification, and cDNA synthesis. Different types of enzymes, such as reverse transcriptase, DNA polymerase, and ligases, find applications specific to the technique employed for gene expression analysis.
Services in gene expression analysis include consultancy, custom assay design, sample preparation, sequencing, data analysis, and interpretation. These are typically offered by specialized companies or academic core facilities to researchers lacking the necessary equipment or expertise.
Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
Gene expression analysis has become integral to clinical diagnostics, enabling the identification of disease-specific biomarkers and facilitating personalized treatment plans. By analyzing the expression levels of genes in patient samples, medical professionals can diagnose diseases at a molecular level, predict disease progression, and monitor patient response to treatment. In drug discovery and development, gene expression analysis is employed to identify potential drug targets, understand the mechanisms of action of new drugs, and predict drug efficacy and toxicity. This leads to the development of more effective and safer drugs, significantly improving the drug development pipeline.
Regional Insights
The gene expression analysis market in the Americas, particularly in North America, has exhibited significant growth. This can be attributed to several factors, including advanced healthcare infrastructure, substantial investments in biotechnology and pharmaceutical research, and the presence of major market players. Initiatives by government bodies, such as the National Institutes of Health (NIH), alongside collaborations between academic institutions and biopharmaceutical companies, also contribute to the robust growth in this region. The rising prevalence of chronic and genetic diseases, combined with supportive government policies related to healthcare research, describes the high adoption of gene expression analysis technology in Europe. Investments in research infrastructure and a rising focus on healthcare improvement, particularly in the Gulf Cooperation Council (GCC) countries, are pivotal factors driving the market in the EMEA. Asia-Pacific is a rapidly growing market for gene expression analysis, with an increasing number of research activities in drug discovery and development, rising healthcare expenditures, and growing awareness about genetic diseases. Moreover, government initiatives aimed at bolstering biotechnology and pharmaceutical sectors and collaborations between academic institutions and industry are notably supporting the market growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Gene Expression Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Expression Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Gene Expression Analysis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Expression Analysis Market?
3. What are the technology trends and regulatory frameworks in the Gene Expression Analysis Market?
4. What is the market share of the leading vendors in the Gene Expression Analysis Market?
5. Which modes and strategic moves are suitable for entering the Gene Expression Analysis Market?